Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8839 |
High Similarity |
NPD1511 |
Approved |
0.8812 |
High Similarity |
NPD2801 |
Approved |
0.8726 |
High Similarity |
NPD1512 |
Approved |
0.865 |
High Similarity |
NPD3749 |
Approved |
0.8571 |
High Similarity |
NPD3818 |
Discontinued |
0.8519 |
High Similarity |
NPD1934 |
Approved |
0.8476 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8476 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8466 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8324 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8294 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8284 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8214 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8176 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8166 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8155 |
Intermediate Similarity |
NPD919 |
Approved |
0.8129 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8113 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8098 |
Intermediate Similarity |
NPD920 |
Approved |
0.8092 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8089 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8086 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8065 |
Intermediate Similarity |
NPD943 |
Approved |
0.8057 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8024 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7988 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7943 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7937 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7904 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7898 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7888 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7862 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7857 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7824 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7785 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7784 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7758 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7758 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7736 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7709 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7707 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7665 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7661 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD5401 |
Approved |
0.765 |
Intermediate Similarity |
NPD4287 |
Approved |
0.765 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7644 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7546 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7541 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7531 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7528 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7458 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD1653 |
Approved |
0.741 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7403 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD1613 |
Approved |
0.738 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7337 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7303 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7257 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7241 |
Intermediate Similarity |
NPD37 |
Approved |
0.7239 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7216 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7207 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7207 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7207 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7197 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7189 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7189 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.717 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7169 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7169 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7161 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7134 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7085 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7072 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7069 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7055 |
Intermediate Similarity |
NPD411 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD17 |
Approved |
0.7005 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.6994 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD6651 |
Approved |
0.6981 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD9494 |
Approved |
0.697 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD1164 |
Approved |
0.6952 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6951 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6939 |
Remote Similarity |
NPD6782 |
Approved |
0.6939 |
Remote Similarity |
NPD6780 |
Approved |
0.6939 |
Remote Similarity |
NPD6781 |
Approved |
0.6939 |
Remote Similarity |
NPD6777 |
Approved |
0.6939 |
Remote Similarity |
NPD6779 |
Approved |
0.6939 |
Remote Similarity |
NPD6778 |
Approved |
0.6939 |
Remote Similarity |
NPD6776 |
Approved |
0.6937 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6931 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD1535 |
Discovery |
0.6918 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6909 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6895 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6889 |
Remote Similarity |
NPD6971 |
Discontinued |
0.6879 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6871 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.686 |
Remote Similarity |
NPD2354 |
Approved |
0.6854 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6851 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6848 |
Remote Similarity |
NPD2403 |
Approved |
0.6845 |
Remote Similarity |
NPD1252 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6821 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6816
|
Remote Similarity |
NPD5760 |
Phase 2 |